{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03276312",
      "OrgStudyIdInfo": {
        "OrgStudyId": "ADF01"
      },
      "Organization": {
        "OrgFullName": "University of Modena and Reggio Emilia",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot",
      "OfficialTitle": "Local Inoculation of Autologous Micro-fragmented Adipose Tissue in the Treatment of Minor Amputations of Diabetic Foot: A Randomized Controlled Trial"
    },
    "StatusModule": {
      "StatusVerifiedDate": "June 2018",
      "OverallStatus": "Completed",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "April 2015",
        "StartDateType": "Actual"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "March 2018",
        "PrimaryCompletionDateType": "Actual"
      },
      "CompletionDateStruct": {
        "CompletionDate": "March 2018",
        "CompletionDateType": "Actual"
      },
      "StudyFirstSubmitDate": "July 24, 2017",
      "StudyFirstSubmitQCDate": "September 7, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "September 8, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "June 6, 2018",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "June 8, 2018",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Principal Investigator",
        "ResponsiblePartyInvestigatorFullName": "Giulia Trevisi Borsari",
        "ResponsiblePartyInvestigatorTitle": "Dr",
        "ResponsiblePartyInvestigatorAffiliation": "University of Modena and Reggio Emilia"
      },
      "LeadSponsor": {
        "LeadSponsorName": "University of Modena and Reggio Emilia",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No",
      "IsFDARegulatedDrug": "No",
      "IsFDARegulatedDevice": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This is a randomized controlled monocentric study on 114 diabetic patients with the aim of evaluating the efficacy of the lipofilling with Lipogems速 system in diabetic patients that are candidates for a minor amputation in the foot. In particular, it will be evaluated whether the lipofilling will be able to shorten the healing times and to reduce the number of major amputations, with consequent positive impact on the quality of life. Patients will be randomized to the treatment group with Lipogems速 (local injection of autologous micro-fractured adipose tissue) or to the control group, thus, treatment according to standard clinical practice.",
      "DetailedDescription": "Primary objective of this study is the evaluation of the time of the healing of the lesions resulting from minor amputations (digital or forefoot) treated with Lipogems速 technique.\n\nSecondary objectives are: 1) assessment of the safety of the lipofilling; 2) evaluation of the intensity of pain (VAS); 3) assessment of the skin tropism; 4) calculation of the relapse rate (defined as the occurrence of local infections, dehiscence and suffering of skin flaps that lead to a revision of the amputation stump or amputation at a higher level); 5) evaluation of the time of hospitalization and quality of life (QoL)."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Diabetic Foot"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "Lipogems",
          "Adipose-derived Mesenchymal Stem Cells",
          "Lipofilling",
          "Diabetic foot"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Not Applicable"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "Randomized",
        "DesignInterventionModel": "Parallel Assignment",
        "DesignInterventionModelDescription": "Randomized controlled study",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "112",
        "EnrollmentType": "Actual"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Intervention",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Lipogems - local injection of autologous micro-fragmented adipose tissue",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Device: Lipogems"
              ]
            }
          },
          {
            "ArmGroupLabel": "Control",
            "ArmGroupType": "No Intervention",
            "ArmGroupDescription": "Routine clinical practice"
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Device",
            "InterventionName": "Lipogems",
            "InterventionDescription": "Lipogems速 is an innovative system that, starting from minimum quantities of autologous lipoaspirate, provides, with a minimal manipulation, a micro-fragmented and non-expanded adipose tissue product",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Intervention"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Healing time",
            "PrimaryOutcomeDescription": "Healing time after the minor amputation intended as the complete healing of the amputation stump",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Safety: All types of adverse events will be collected",
            "SecondaryOutcomeDescription": "All types of adverse events will be collected",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Incidence of relapse",
            "SecondaryOutcomeDescription": "Relapse is intended as revision of the amputation stump or amputation at a higher level",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Pain assessed using the Visual Analogue Scale (VAS) for pain",
            "SecondaryOutcomeDescription": "Pain will be assessed using the VAS pain scale",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Total time of hospitalization",
            "SecondaryOutcomeDescription": "Hospitalization of the patient will be assessed counting the number of days in hospital",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Total time of immobility",
            "SecondaryOutcomeDescription": "Immobility of the patient will be assessed counting the number of bed rest days",
            "SecondaryOutcomeTimeFrame": "6 months"
          },
          {
            "SecondaryOutcomeMeasure": "Quality of Life using the Short Form 36 (SF-36) questionnaire",
            "SecondaryOutcomeDescription": "Assessment of the quality of life (QoL) before surgery and during all the subsequent follow up visits using the SF-36 questionnaire",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nPatients with diabetes (diabetes mellitus type 1 and type 2) of both sexes over the age of 18 years.\nPresence of irreversible gangrene digital or localized at forefoot (with X-ray of the foot negative or positive for osteolytic lesions at phalanges and/or metatarsus).\nPatients with vascular problems absent or resolved (evaluated with Eco Color Doppler and ABI (Ankle Brachial Index, that calculates the ratio of the systolic pressure measured at the ankle and the systolic pressure in the arm, both measured in supine position using wave continue Doppler. If assessable, it has to be greater than/equal to 0.7) and pressure index finger/arm TBI (Toe Brachial Index, if assessable, it has to be greater than/equal to 0.6) and/or by the determination of the transcutaneous oxygen pressure (TcPO2 that needs to be equal to or greater than 30mmHg).\n\nExclusion Criteria:\n\nOncological treatments ongoing or previous (past 5 years) and/or neoplastic lesions\nPatient under steroid therapy\nActive vascular issues",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "18 Years",
      "StdAgeList": {
        "StdAge": [
          "Adult",
          "Older Adult"
        ]
      }
    },
    "ContactsLocationsModule": {
      "OverallOfficialList": {
        "OverallOfficial": [
          {
            "OverallOfficialName": "Roberto Silingardi, Prof",
            "OverallOfficialAffiliation": "Baggiovara Hospital, Vascular Surgery department",
            "OverallOfficialRole": "Principal Investigator"
          }
        ]
      },
      "LocationList": {
        "Location": [
          {
            "LocationFacility": "University of Modena and Reggio Emilia",
            "LocationCity": "Modena",
            "LocationZip": "41100",
            "LocationCountry": "Italy"
          }
        ]
      }
    },
    "ReferencesModule": {
      "ReferenceList": {
        "Reference": [
          {
            "ReferencePMID": "34515448",
            "ReferenceType": "derived",
            "ReferenceCitation": "Gennai S, Leone N, Covic T, Migliari M, Lonardi R, Silingardi R. Health-related quality of life outcomes and hospitalization length of stay after micro-fragmented autologous adipose tissue injection in minor amputations for diabetic foot ulceration (MiFrAADiF Trial): results from a randomized controlled single-center clinical trial. Int Angiol. 2021 Dec;40(6):512-519. doi: 10.23736/S0392-9590.21.04570-3. Epub 2021 Sep 13."
          },
          {
            "ReferencePMID": "31358046",
            "ReferenceType": "derived",
            "ReferenceCitation": "Lonardi R, Leone N, Gennai S, Trevisi Borsari G, Covic T, Silingardi R. Autologous micro-fragmented adipose tissue for the treatment of diabetic foot minor amputations: a randomized controlled single-center clinical trial (MiFrAADiF). Stem Cell Res Ther. 2019 Jul 29;10(1):223. doi: 10.1186/s13287-019-1328-4."
          }
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "No"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000017719",
            "ConditionMeshTerm": "Diabetic Foot"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000003925",
            "ConditionAncestorTerm": "Diabetic Angiopathies"
          },
          {
            "ConditionAncestorId": "D000014652",
            "ConditionAncestorTerm": "Vascular Diseases"
          },
          {
            "ConditionAncestorId": "D000002318",
            "ConditionAncestorTerm": "Cardiovascular Diseases"
          },
          {
            "ConditionAncestorId": "D000016523",
            "ConditionAncestorTerm": "Foot Ulcer"
          },
          {
            "ConditionAncestorId": "D000007871",
            "ConditionAncestorTerm": "Leg Ulcer"
          },
          {
            "ConditionAncestorId": "D000012883",
            "ConditionAncestorTerm": "Skin Ulcer"
          },
          {
            "ConditionAncestorId": "D000012871",
            "ConditionAncestorTerm": "Skin Diseases"
          },
          {
            "ConditionAncestorId": "D000048909",
            "ConditionAncestorTerm": "Diabetes Complications"
          },
          {
            "ConditionAncestorId": "D000003920",
            "ConditionAncestorTerm": "Diabetes Mellitus"
          },
          {
            "ConditionAncestorId": "D000004700",
            "ConditionAncestorTerm": "Endocrine System Diseases"
          },
          {
            "ConditionAncestorId": "D000003929",
            "ConditionAncestorTerm": "Diabetic Neuropathies"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M19085",
            "ConditionBrowseLeafName": "Diabetic Foot",
            "ConditionBrowseLeafAsFound": "Diabetic Foot",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M6272",
            "ConditionBrowseLeafName": "Diabetic Angiopathies",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16552",
            "ConditionBrowseLeafName": "Vascular Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M16358",
            "ConditionBrowseLeafName": "Ulcer",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M18071",
            "ConditionBrowseLeafName": "Foot Ulcer",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M10035",
            "ConditionBrowseLeafName": "Leg Ulcer",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14838",
            "ConditionBrowseLeafName": "Skin Ulcer",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M14826",
            "ConditionBrowseLeafName": "Skin Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6267",
            "ConditionBrowseLeafName": "Diabetes Mellitus",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M25157",
            "ConditionBrowseLeafName": "Diabetes Complications",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M7014",
            "ConditionBrowseLeafName": "Endocrine System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M6276",
            "ConditionBrowseLeafName": "Diabetic Neuropathies",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC14",
            "ConditionBrowseBranchName": "Heart and Blood Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC17",
            "ConditionBrowseBranchName": "Skin and Connective Tissue Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC19",
            "ConditionBrowseBranchName": "Gland and Hormone Related Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC18",
            "ConditionBrowseBranchName": "Nutritional and Metabolic Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          }
        ]
      }
    },
    "InterventionBrowseModule": {
      "InterventionBrowseLeafList": {
        "InterventionBrowseLeaf": [
          {
            "InterventionBrowseLeafId": "M16512",
            "InterventionBrowseLeafName": "Vaccines",
            "InterventionBrowseLeafRelevance": "low"
          }
        ]
      },
      "InterventionBrowseBranchList": {
        "InterventionBrowseBranch": [
          {
            "InterventionBrowseBranchAbbrev": "All",
            "InterventionBrowseBranchName": "All Drugs and Chemicals"
          }
        ]
      }
    }
  }
}